Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Best Stocks Under $2 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Ur Energy stock logo

1. Ur Energy NYSEAMERICAN:URG

$0.81 0.00 (-0.59%)
Closing price 10/23/2026 04:10 PM Eastern
Extended Trading
$0.82 +0.01 (+1.13%)
As of 10/23/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$323.30 million
Consensus Rating
Buy
Consensus Price Target
$2.28 (+181.2% Upside)
Volume
10.64 million shares
Average Volume
10.45 million shares
Today's Range
$0.79
▼
$0.83
Nouveau Monde Graphite stock logo

2. Nouveau Monde Graphite NYSE:NMG

$0.94 +0.05 (+6.16%)
Closing price 10/23/2026 03:58 PM Eastern
Extended Trading
$0.95 +0.00 (+0.21%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization
$310.07 million
Consensus Rating
Buy
Consensus Price Target
$3.87 (+310.0% Upside)
Volume
304,251 shares
Average Volume
541,174 shares
Today's Range
$0.87
▼
$0.95
Stereotaxis stock logo

3. Stereotaxis NYSEAMERICAN:STXS

$1.02 +0.02 (+2.20%)
Closing price 10/23/2026 04:10 PM Eastern
Extended Trading
$1.02 +0.00 (+0.49%)
As of 10/23/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization
$102.21 million
Consensus Rating
Buy
Consensus Price Target
$3.50 (+243.1% Upside)
Volume
420,569 shares
Average Volume
590,727 shares
Today's Range
$0.99
▼
$1.04
Perspective Therapeutics stock logo

4. Perspective Therapeutics NYSEAMERICAN:CATX

$1.61 -0.65 (-28.76%)
Closing price 10/23/2026 04:10 PM Eastern
Extended Trading
$1.64 +0.03 (+2.17%)
As of 10/23/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$183.78 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+614.3% Upside)
Volume
5.60 million shares
Average Volume
1.70 million shares
Today's Range
$1.58
▼
$2.40
Palisade Bio stock logo

5. Palisade Bio NASDAQ:PALI

$1.33 -0.02 (-1.48%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.34 +0.00 (+0.38%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization
$231.78 million
Consensus Rating
Buy
Consensus Price Target
$9.29 (+598.2% Upside)
Volume
1.15 million shares
Average Volume
2.73 million shares
Today's Range
$1.28
▼
$1.37
iBio stock logo

6. iBio NASDAQ:IBIO

$0.72 -0.07 (-8.44%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.72 +0.00 (+0.59%)
As of 10/23/2026 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$46.16 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+735.9% Upside)
Volume
653,854 shares
Average Volume
864,608 shares
Today's Range
$0.71
▼
$0.78
Compugen stock logo

7. Compugen NASDAQ:CGEN

$1.94 -0.02 (-1.02%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.96 +0.03 (+1.29%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about Compugen

Market Capitalization
$183.43 million
P/E Ratio
5.11
Consensus Rating
Buy
Consensus Price Target
$5.00 (+157.7% Upside)
Volume
148,020 shares
Average Volume
217,202 shares
Equillium stock logo

8. Equillium NASDAQ:EQ

$1.23 -0.04 (-3.15%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.24 +0.01 (+0.41%)
As of 10/23/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization
$77.99 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.57 (+515.6% Upside)
Volume
315,633 shares
Average Volume
735,587 shares
Today's Range
$1.18
▼
$1.29
Inhibikase Therapeutics stock logo

9. Inhibikase Therapeutics NASDAQ:IKT

$1.59 -0.04 (-2.45%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.60 +0.01 (+0.63%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$221.86 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.75 (+198.7% Upside)
Volume
408,794 shares
Average Volume
636,549 shares
Today's Range
$1.54
▼
$1.65
Cabaletta Bio stock logo

10. Cabaletta Bio NASDAQ:CABA

$1.47 -0.05 (-3.29%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.49 +0.02 (+1.50%)
As of 10/23/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cabaletta Bio, Inc, a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. More about Cabaletta Bio

Market Capitalization
$249.23 million
Consensus Rating
Moderate Buy
Consensus Price Target
$15.60 (+961.2% Upside)
Volume
3.99 million shares
Average Volume
5.05 million shares
Today's Range
$1.39
▼
$1.50
Tvardi Therapeutics stock logo

11. Tvardi Therapeutics NASDAQ:TVRD

$0.94 -0.03 (-3.31%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.94 +0.01 (+0.53%)
As of 10/23/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. More about Tvardi Therapeutics

Market Capitalization
$12.54 million
Consensus Rating
Moderate Buy
Consensus Price Target
$9.40 (+900.0% Upside)
Volume
108,053 shares
Average Volume
201,987 shares
Today's Range
$0.92
▼
$1.07
Nkarta stock logo

12. Nkarta NASDAQ:NKTX

$1.79 +0.05 (+2.87%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.79 +0.00 (+0.22%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$128.21 million
Consensus Rating
Moderate Buy
Consensus Price Target
$11.20 (+525.7% Upside)
Volume
959,153 shares
Average Volume
860,867 shares
Today's Range
$1.66
▼
$1.81
Tenaya Therapeutics stock logo

13. Tenaya Therapeutics NASDAQ:TNYA

$0.39 +0.00 (+0.26%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.39 0.00 (0.00%)
As of 10/23/2026 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization
$87.23 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.00 (+928.3% Upside)
Volume
1.68 million shares
Average Volume
4.22 million shares
Today's Range
$0.38
▼
$0.40
Autolus Therapeutics stock logo

14. Autolus Therapeutics NASDAQ:AUTL

$1.54 -0.04 (-2.53%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.53 -0.01 (-0.39%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization
$409.89 million
Consensus Rating
Moderate Buy
Consensus Price Target
$10.00 (+549.4% Upside)
Volume
1.53 million shares
Average Volume
1.78 million shares
Today's Range
$1.50
▼
$1.58
Tritax Big Box REIT stock logo

15. Tritax Big Box REIT OTCMKTS:TTBXF

$1.95 0.00 (0.00%)
As of 10/23/2026

Tritax Big Box REIT plc (ticker: BBOX) is the largest listed investor in high-quality logistics warehouse assets and controls the largest logistics-focused land platform in the UK. More about Tritax Big Box REIT

Market Capitalization
$5.27 billion
Consensus Rating
Moderate Buy
Average Volume
6,575 shares
Today's Range
$1.95
▼
$1.95
50-Day Range
$1.61
▼
$2.06
52-Week Range
$1.61
▼
$2.43

16. NervGen Pharma NASDAQ:NGEN

$1.43 +0.01 (+0.70%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.43 0.00 (0.00%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen Pharma

Market Capitalization
$115.30 million
Consensus Rating
Moderate Buy
Consensus Price Target
$14.00 (+879.0% Upside)
Volume
943,976 shares
Average Volume
472,912 shares
Today's Range
$1.38
▼
$1.44
Cellectar Biosciences stock logo

17. Cellectar Biosciences NASDAQ:CLRB

$1.22 +0.05 (+4.27%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.25 +0.03 (+2.46%)
As of 10/23/2026 06:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cellectar Biosciences, Inc, a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. More about Cellectar Biosciences

Market Capitalization
$11.53 million
Consensus Rating
Moderate Buy
Consensus Price Target
$11.00 (+801.6% Upside)
Volume
55,969 shares
Average Volume
168,281 shares
Today's Range
$1.14
▼
$1.22
PMV Pharmaceuticals stock logo

18. PMV Pharmaceuticals NASDAQ:PMVP

$1.27 -0.04 (-2.68%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.27 +0.00 (+0.39%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV Pharmaceuticals

Market Capitalization
$67.89 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.33 (+241.2% Upside)
Volume
170,992 shares
Average Volume
827,223 shares
Today's Range
$1.26
▼
$1.33
Allogene Therapeutics stock logo

19. Allogene Therapeutics NASDAQ:ALLO

$1.25 0.00 (0.00%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.26 +0.01 (+0.80%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Allogene Therapeutics, Inc, a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. More about Allogene Therapeutics

Market Capitalization
$431.86 million
Consensus Rating
Moderate Buy
Consensus Price Target
$8.30 (+564.0% Upside)
Volume
8.40 million shares
Average Volume
5.68 million shares
Today's Range
$1.16
▼
$1.26
Connect Biopharma stock logo

20. Connect Biopharma NASDAQ:CNTB

$0.77 +0.00 (+0.58%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.75 -0.02 (-2.02%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. More about Connect Biopharma

Market Capitalization
$48.27 million
Consensus Rating
Moderate Buy
Consensus Price Target
$5.88 (+666.5% Upside)
Volume
342,532 shares
Average Volume
10.00 million shares
Today's Range
$0.74
▼
$0.78
Neumora Therapeutics stock logo

21. Neumora Therapeutics NASDAQ:NMRA

$0.38 -0.03 (-6.48%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.41 +0.03 (+8.07%)
As of 10/23/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neumora Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. More about Neumora Therapeutics

Market Capitalization
$71.29 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.57 (+1,632.1% Upside)
Volume
830,751 shares
Average Volume
2.25 million shares
Today's Range
$0.37
▼
$0.41
Compass Therapeutics stock logo

22. Compass Therapeutics NASDAQ:CMPX

$0.76 -0.04 (-5.05%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.78 +0.02 (+2.10%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization
$137.05 million
Consensus Rating
Moderate Buy
Consensus Price Target
$10.25 (+1,246.9% Upside)
Volume
2.13 million shares
Average Volume
5.56 million shares
Today's Range
$0.75
▼
$0.81
Kodiak AI stock logo

23. Kodiak AI NASDAQ:KDK

$1.02 -0.02 (-1.92%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.04 +0.02 (+1.96%)
As of 10/23/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. More about Kodiak AI

Market Capitalization
$204.63 million
Consensus Rating
Moderate Buy
Consensus Price Target
$9.69 (+849.8% Upside)
Volume
9.87 million shares
Average Volume
7.55 million shares
Today's Range
$0.96
▼
$1.06
Kalaris Therapeutics stock logo

24. Kalaris Therapeutics NASDAQ:KLRS

$1.87 -0.12 (-6.03%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$1.87 +0.00 (+0.05%)
As of 10/23/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Allovir, Inc, a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. More about Kalaris Therapeutics

Market Capitalization
$44.52 million
Consensus Rating
Moderate Buy
Consensus Price Target
$18.75 (+902.7% Upside)
Volume
25,406 shares
Average Volume
89,632 shares
Today's Range
$1.87
▼
$1.99
Milestone Pharmaceuticals stock logo

25. Milestone Pharmaceuticals NASDAQ:MIST

$0.65 -0.05 (-7.76%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$0.68 +0.03 (+5.06%)
As of 10/23/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Milestone Pharmaceuticals Inc, a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. More about Milestone Pharmaceuticals

Market Capitalization
$80.70 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.40 (+887.3% Upside)
Volume
1.55 million shares
Average Volume
951,894 shares
Today's Range
$0.63
▼
$0.71